Qsrc Limited

The principal activity of the Company is to provide specialised intracranial stereotactic radiosurgery treatments for NHS and private patients under contractual arrangements. QSRC Ltd is the primary operator of the specialised Elekta GammaKnife radiosurgery system for treating a wide range of previously inoperable brain lesions on behalf of University College London Hospitals NHS Foundation Trust. It provides this service under long term NHS contracts with both the Trust (which runs to December 2028) and with NHS England, under a national Specialised Services Commissioning agreement involving the three parties (eg: UCLH, NHSE and QSRC). QSRC is recognised by NHSE as a “Supra National” service (only one of two such Centres in the UK) to treat the full range of intracranial conditions including secondary Brain Metastases, Skull Base and Pituitary Brain Tumours, Neuro-Vascular lesions such as Arterial Vascular Malformation (AVMs), and other highly complex disorders such as Trigeminal Neuralgia. As a recognised NHS Supra Centre, QSRC is a leading national and international Intracranial Stereotactic Radiosurgery Treatment Centre. QSRC also provides a highly specialised paediatric intracranial treatment service for neurosurgical patients under the care of Great Ormond Street Hospital for Children NHS Foundation Trust.